Vastagbélrák: vizsgálatok itt: Portugália
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Lisbon, Loures, Porto
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Lisbon, Porto
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
- Where
- Coimbra, Lisbon, Porto
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00 - 3. fázisTaking peopleA Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Where
- Almada, Guimaraes, Lisbon, Loures, Porto
- Életkor
- 18 év and over
- People
- 990 worldwide
- Run by
- AbbVie
See details and how to joinNCT07525206 · EU 2025-521712-19-00 - No phaseTaking peopleMulticentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Diagnostic Methods
- Where
- Porto
- Életkor
- 18 év and over
- People
- 4100 worldwide
- Run by
- Firalis SA
See details and how to joinNCT06515821 - 1. fázisTaking peopleA phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
- Where
- Porto
- Életkor
- 18 év and over
- People
- 62 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521702-18-00 · EU 2025-521702-18-00 - 3. fázisTaking peopleStudy of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Where
- Almada, Coimbra, Lisbon, Matosinhos Municipality, Santa Maria da Feira
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Amgen
See details and how to joinNCT06252649 - 3. fázisTaking peopleSotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
- Where
- Almada, Coimbra, Lisbon, Santa Maria Da Feira, Senhora Da Hora
- Életkor
- 18 év to 64 év
- People
- 241 worldwide
- Run by
- Amgen Inc.
See details and how to join2022-502352-31-00 · EU 2022-502352-31-00 - 3. fázisTaking peopleA Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Where
- Almada, Guarda, Lisbon, Porto
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05253651 · EU 2024-514180-25-00 - No phaseTaking peopleImproving Colorectal Cancer Early Screening in Portugal: Identification of Gut Microbiome Biomarkers in Stool (GUTBIOME-PT)
- Where
- Lisbon
- Életkor
- 40 év to 74 év
- People
- 30 000
- Run by
- Gulbenkian Institute for Molecular Medicine
See details and how to joinNCT06741293 - No phaseTaking peopleCARE-CRC: Microbiome Insights and Correlations for Risk and Outcomes in Colorectal Cancer
- Where
- Lisbon
- Életkor
- 40 év to 74 év
- People
- 400
- Run by
- Gulbenkian Institute for Molecular Medicine
See details and how to joinNCT06734156 - 3. fázisTaking peopleStudy of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Where
- Almada, Coimbra, Lisbon
- Életkor
- 18 év and over
- People
- 892 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05855200 · EU 2023-503265-27-00 - No phaseTaking peopleExploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
- Where
- Lisbon
- Életkor
- 50 év to 69 év
- People
- 1000 worldwide
- Run by
- ADVANCED MARKER DISCOVERY S.L.
See details and how to joinNCT06696534 - No phaseTaking peopleIntervention Project to Increase Adherence to Colorectal Cancer Screening in Barcelos/Esposende
- Where
- Porto
- Életkor
- 49 év to 75 év
- People
- 1038
- Run by
- Local Health Unit Barcelos/Esposende, Public Health Unit
See details and how to joinNCT06972160 - No phaseTaking peopleEvaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
- Where
- Lisbon
- Életkor
- 50 év to 69 év
- People
- 4538 worldwide
- Run by
- ADVANCED MARKER DISCOVERY S.L.
See details and how to joinNCT06703632 - 3. fázisTaking peopleInduction Chemotherapy for Locally Recurrent Rectal Cancer
- Where
- Lisbon
- Életkor
- 18 év and over
- People
- 364 worldwide
- Run by
- Catharina Ziekenhuis Eindhoven
See details and how to joinNCT04389086 · EU 2024-512526-28-00